The Biopharmaceutical Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biopharmaceutical Contract Manufacturing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Autoimmune Diseases accounting for % of the Biopharmaceutical Contract Manufacturing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Growth Factors segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biopharmaceutical Contract Manufacturing include Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biopharmaceutical Contract Manufacturing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Growth Factors
- Interferons
- Monoclonal Antibodies
- Recombinant Hormones
- Vaccines
- Insulin
- Others
Market segment by Application, can be divided into
- Autoimmune Diseases
- Oncology
- Metabolic Diseases
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Neurology
- Respiratory Disorders
- Others
Market segment by players, this report covers
- Lonza Group
- Baxter Biopharma Solutions
- Samsung
- Fujifilm Diosynth Biotechnologies
- Boehringer Ingelheim
- Patheon
- Rentschler Biotechnologie
- Biomeva
- Probiogen
- Cytovance Biologics
- KBI Biopharma
- WuXi Biologics
- Abzena
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biopharmaceutical Contract Manufacturing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biopharmaceutical Contract Manufacturing, with revenue, gross margin and global market share of Biopharmaceutical Contract Manufacturing from 2019 to 2022.
Chapter 3, the Biopharmaceutical Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biopharmaceutical Contract Manufacturing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biopharmaceutical Contract Manufacturing research findings and conclusion, appendix and data source.
Global Biopharmaceutical Contract Manufacturing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Biopharmaceutical Contract Manufacturing
1.2 Classification of Biopharmaceutical Contract Manufacturing by Type
1.2.1 Overview: Global Biopharmaceutical Contract Manufacturing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type in 2021
1.2.3 Growth Factors
1.2.4 Interferons
1.2.5 Monoclonal Antibodies
1.2.6 Recombinant Hormones
1.2.7 Vaccines
1.2.8 Insulin
1.2.9 Others
1.3 Global Biopharmaceutical Contract Manufacturing Market by Application
1.3.1 Overview: Global Biopharmaceutical Contract Manufacturing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Global Biopharmaceutical Contract Manufacturing Market Size & Forecast
1.5 Global Biopharmaceutical Contract Manufacturing Market Size and Forecast by Region
1.5.1 Global Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biopharmaceutical Contract Manufacturing Market Size by Region, (2017-2022)
1.5.3 North America Biopharmaceutical Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.4 Europe Biopharmaceutical Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.6 South America Biopharmaceutical Contract Manufacturing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical Contract Manufacturing Market Drivers
1.6.2 Biopharmaceutical Contract Manufacturing Market Restraints
1.6.3 Biopharmaceutical Contract Manufacturing Trends Analysis
2 Company Profiles
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Product and Solutions
2.1.4 Lonza Group Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Baxter Biopharma Solutions
2.2.1 Baxter Biopharma Solutions Details
2.2.2 Baxter Biopharma Solutions Major Business
2.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product and Solutions
2.2.4 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Baxter Biopharma Solutions Recent Developments and Future Plans
2.3 Samsung
2.3.1 Samsung Details
2.3.2 Samsung Major Business
2.3.3 Samsung Biopharmaceutical Contract Manufacturing Product and Solutions
2.3.4 Samsung Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Samsung Recent Developments and Future Plans
2.4 Fujifilm Diosynth Biotechnologies
2.4.1 Fujifilm Diosynth Biotechnologies Details
2.4.2 Fujifilm Diosynth Biotechnologies Major Business
2.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product and Solutions
2.4.4 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product and Solutions
2.5.4 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
2.6 Patheon
2.6.1 Patheon Details
2.6.2 Patheon Major Business
2.6.3 Patheon Biopharmaceutical Contract Manufacturing Product and Solutions
2.6.4 Patheon Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Patheon Recent Developments and Future Plans
2.7 Rentschler Biotechnologie
2.7.1 Rentschler Biotechnologie Details
2.7.2 Rentschler Biotechnologie Major Business
2.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product and Solutions
2.7.4 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Rentschler Biotechnologie Recent Developments and Future Plans
2.8 Biomeva
2.8.1 Biomeva Details
2.8.2 Biomeva Major Business
2.8.3 Biomeva Biopharmaceutical Contract Manufacturing Product and Solutions
2.8.4 Biomeva Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Biomeva Recent Developments and Future Plans
2.9 Probiogen
2.9.1 Probiogen Details
2.9.2 Probiogen Major Business
2.9.3 Probiogen Biopharmaceutical Contract Manufacturing Product and Solutions
2.9.4 Probiogen Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Probiogen Recent Developments and Future Plans
2.10 Cytovance Biologics
2.10.1 Cytovance Biologics Details
2.10.2 Cytovance Biologics Major Business
2.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
2.10.4 Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Cytovance Biologics Recent Developments and Future Plans
2.11 KBI Biopharma
2.11.1 KBI Biopharma Details
2.11.2 KBI Biopharma Major Business
2.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Product and Solutions
2.11.4 KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 KBI Biopharma Recent Developments and Future Plans
2.12 WuXi Biologics
2.12.1 WuXi Biologics Details
2.12.2 WuXi Biologics Major Business
2.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
2.12.4 WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 WuXi Biologics Recent Developments and Future Plans
2.13 Abzena
2.13.1 Abzena Details
2.13.2 Abzena Major Business
2.13.3 Abzena Biopharmaceutical Contract Manufacturing Product and Solutions
2.13.4 Abzena Biopharmaceutical Contract Manufacturing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Abzena Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biopharmaceutical Contract Manufacturing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biopharmaceutical Contract Manufacturing Players Market Share in 2021
3.2.2 Top 10 Biopharmaceutical Contract Manufacturing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biopharmaceutical Contract Manufacturing Players Head Office, Products and Services Provided
3.4 Biopharmaceutical Contract Manufacturing Mergers & Acquisitions
3.5 Biopharmaceutical Contract Manufacturing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biopharmaceutical Contract Manufacturing Revenue and Market Share by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2028)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country
6.3.1 North America Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2028)
6.3.2 United States Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
6.3.3 Canada Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
6.3.4 Mexico Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2028)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country
7.3.1 Europe Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2028)
7.3.2 Germany Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.3 France Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.5 Russia Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
7.3.6 Italy Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2028)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Region (2017-2028)
8.3.2 China Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.3 Japan Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.4 South Korea Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.5 India Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
8.3.7 Australia Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2028)
9.2 South America Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2028)
9.3 South America Biopharmaceutical Contract Manufacturing Market Size by Country
9.3.1 South America Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2028)
9.3.2 Brazil Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
9.3.3 Argentina Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2028)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2028)
10.3.2 Turkey Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
10.3.4 UAE Biopharmaceutical Contract Manufacturing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biopharmaceutical Contract Manufacturing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biopharmaceutical Contract Manufacturing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Region (2023-2028)
Table 6. Lonza Group Corporate Information, Head Office, and Major Competitors
Table 7. Lonza Group Major Business
Table 8. Lonza Group Biopharmaceutical Contract Manufacturing Product and Solutions
Table 9. Lonza Group Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Baxter Biopharma Solutions Corporate Information, Head Office, and Major Competitors
Table 11. Baxter Biopharma Solutions Major Business
Table 12. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product and Solutions
Table 13. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Samsung Corporate Information, Head Office, and Major Competitors
Table 15. Samsung Major Business
Table 16. Samsung Biopharmaceutical Contract Manufacturing Product and Solutions
Table 17. Samsung Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Fujifilm Diosynth Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 19. Fujifilm Diosynth Biotechnologies Major Business
Table 20. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product and Solutions
Table 21. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 23. Boehringer Ingelheim Major Business
Table 24. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product and Solutions
Table 25. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Patheon Corporate Information, Head Office, and Major Competitors
Table 27. Patheon Major Business
Table 28. Patheon Biopharmaceutical Contract Manufacturing Product and Solutions
Table 29. Patheon Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Rentschler Biotechnologie Corporate Information, Head Office, and Major Competitors
Table 31. Rentschler Biotechnologie Major Business
Table 32. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product and Solutions
Table 33. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Biomeva Corporate Information, Head Office, and Major Competitors
Table 35. Biomeva Major Business
Table 36. Biomeva Biopharmaceutical Contract Manufacturing Product and Solutions
Table 37. Biomeva Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Probiogen Corporate Information, Head Office, and Major Competitors
Table 39. Probiogen Major Business
Table 40. Probiogen Biopharmaceutical Contract Manufacturing Product and Solutions
Table 41. Probiogen Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Cytovance Biologics Corporate Information, Head Office, and Major Competitors
Table 43. Cytovance Biologics Major Business
Table 44. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
Table 45. Cytovance Biologics Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. KBI Biopharma Corporate Information, Head Office, and Major Competitors
Table 47. KBI Biopharma Major Business
Table 48. KBI Biopharma Biopharmaceutical Contract Manufacturing Product and Solutions
Table 49. KBI Biopharma Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. WuXi Biologics Corporate Information, Head Office, and Major Competitors
Table 51. WuXi Biologics Major Business
Table 52. WuXi Biologics Biopharmaceutical Contract Manufacturing Product and Solutions
Table 53. WuXi Biologics Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Abzena Corporate Information, Head Office, and Major Competitors
Table 55. Abzena Major Business
Table 56. Abzena Biopharmaceutical Contract Manufacturing Product and Solutions
Table 57. Abzena Biopharmaceutical Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Biopharmaceutical Contract Manufacturing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Biopharmaceutical Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Biopharmaceutical Contract Manufacturing Players Head Office, Products and Services Provided
Table 62. Biopharmaceutical Contract Manufacturing Mergers & Acquisitions in the Past Five Years
Table 63. Biopharmaceutical Contract Manufacturing New Entrants and Expansion Plans
Table 64. Global Biopharmaceutical Contract Manufacturing Revenue (USD Million) by Type (2017-2022)
Table 65. Global Biopharmaceutical Contract Manufacturing Revenue Share by Type (2017-2022)
Table 66. Global Biopharmaceutical Contract Manufacturing Revenue Forecast by Type (2023-2028)
Table 67. Global Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022)
Table 68. Global Biopharmaceutical Contract Manufacturing Revenue Forecast by Application (2023-2028)
Table 69. North America Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Biopharmaceutical Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Biopharmaceutical Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Biopharmaceutical Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Biopharmaceutical Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Biopharmaceutical Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Biopharmaceutical Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Biopharmaceutical Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Biopharmaceutical Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Biopharmaceutical Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Biopharmaceutical Contract Manufacturing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biopharmaceutical Contract Manufacturing Picture
Figure 2. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type in 2021
Figure 3. Growth Factors
Figure 4. Interferons
Figure 5. Monoclonal Antibodies
Figure 6. Recombinant Hormones
Figure 7. Vaccines
Figure 8. Insulin
Figure 9. Others
Figure 10. Biopharmaceutical Contract Manufacturing Revenue Market Share by Application in 2021
Figure 11. Autoimmune Diseases Picture
Figure 12. Oncology Picture
Figure 13. Metabolic Diseases Picture
Figure 14. Ophthalmology Picture
Figure 15. Cardiovascular Diseases Picture
Figure 16. Infectious Diseases Picture
Figure 17. Neurology Picture
Figure 18. Respiratory Disorders Picture
Figure 19. Others Picture
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 21. Global Biopharmaceutical Contract Manufacturing Revenue and Forecast (2017-2028) & (USD Million)
Figure 22. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Region (2017-2028)
Figure 23. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Region in 2021
Figure 24. North America Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Europe Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 27. South America Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 28. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 29. Biopharmaceutical Contract Manufacturing Market Drivers
Figure 30. Biopharmaceutical Contract Manufacturing Market Restraints
Figure 31. Biopharmaceutical Contract Manufacturing Market Trends
Figure 32. Lonza Group Recent Developments and Future Plans
Figure 33. Baxter Biopharma Solutions Recent Developments and Future Plans
Figure 34. Samsung Recent Developments and Future Plans
Figure 35. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
Figure 36. Boehringer Ingelheim Recent Developments and Future Plans
Figure 37. Patheon Recent Developments and Future Plans
Figure 38. Rentschler Biotechnologie Recent Developments and Future Plans
Figure 39. Biomeva Recent Developments and Future Plans
Figure 40. Probiogen Recent Developments and Future Plans
Figure 41. Cytovance Biologics Recent Developments and Future Plans
Figure 42. KBI Biopharma Recent Developments and Future Plans
Figure 43. WuXi Biologics Recent Developments and Future Plans
Figure 44. Abzena Recent Developments and Future Plans
Figure 45. Global Biopharmaceutical Contract Manufacturing Revenue Share by Players in 2021
Figure 46. Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Biopharmaceutical Contract Manufacturing Revenue Market Share in 2021
Figure 48. Global Top 10 Players Biopharmaceutical Contract Manufacturing Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Biopharmaceutical Contract Manufacturing Revenue Share by Type in 2021
Figure 51. Global Biopharmaceutical Contract Manufacturing Market Share Forecast by Type (2023-2028)
Figure 52. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application in 2021
Figure 53. Global Biopharmaceutical Contract Manufacturing Market Share Forecast by Application (2023-2028)
Figure 54. North America Biopharmaceutical Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 55. North America Biopharmaceutical Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 56. North America Biopharmaceutical Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 57. United States Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Biopharmaceutical Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 61. Europe Biopharmaceutical Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 62. Europe Biopharmaceutical Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 63. Germany Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Biopharmaceutical Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Biopharmaceutical Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Biopharmaceutical Contract Manufacturing Revenue Market Share by Region (2017-2028)
Figure 71. China Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Biopharmaceutical Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 78. South America Biopharmaceutical Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 79. South America Biopharmaceutical Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Biopharmaceutical Contract Manufacturing Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Biopharmaceutical Contract Manufacturing Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Biopharmaceutical Contract Manufacturing Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Biopharmaceutical Contract Manufacturing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
